[{"orgOrder":0,"company":"YAKULT HONSHA CO LTD","sponsor":"YAKULT HONSHA CO LTD","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Fermented Milk","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"YAKULT HONSHA CO LTD","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"YAKULT HONSHA CO LTD \/ YAKULT HONSHA CO LTD","highestDevelopmentStatusID":"1","companyTruncated":"YAKULT HONSHA CO LTD \/ YAKULT HONSHA CO LTD"},{"orgOrder":0,"company":"YAKULT HONSHA CO LTD","sponsor":"YAKULT HONSHA CO LTD","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"4'-Galactooligosaccharide","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"YAKULT HONSHA CO LTD","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"YAKULT HONSHA CO LTD \/ YAKULT HONSHA CO LTD","highestDevelopmentStatusID":"1","companyTruncated":"YAKULT HONSHA CO LTD \/ YAKULT HONSHA CO LTD"},{"orgOrder":0,"company":"YAKULT HONSHA CO LTD","sponsor":"YAKULT HONSHA CO LTD","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"","productType":"Probiotic","year":"2021","type":"Inapplicable","leadProduct":"Yakult","moa":"Undisclosed","graph1":"Musculoskeletal","graph2":"Undisclosed","graph3":"YAKULT HONSHA CO LTD","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"YAKULT HONSHA CO LTD \/ YAKULT HONSHA CO LTD","highestDevelopmentStatusID":"1","companyTruncated":"YAKULT HONSHA CO LTD \/ YAKULT HONSHA CO LTD"},{"orgOrder":0,"company":"YAKULT HONSHA CO LTD","sponsor":"YAKULT HONSHA CO LTD","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Probiotic","year":"2022","type":"Inapplicable","leadProduct":"Yakult","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"YAKULT HONSHA CO LTD","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"YAKULT HONSHA CO LTD \/ YAKULT HONSHA CO LTD","highestDevelopmentStatusID":"1","companyTruncated":"YAKULT HONSHA CO LTD \/ YAKULT HONSHA CO LTD"},{"orgOrder":0,"company":"YAKULT HONSHA CO LTD","sponsor":"Bach Mai Hospital | Vietnam National University","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"JAPAN","productType":"Probiotic","year":"2023","type":"Inapplicable","leadProduct":"Lactobacillus Casei Strain Shirota Fermented Milk","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"YAKULT HONSHA CO LTD","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"YAKULT HONSHA CO LTD \/ Bach Mai Hospital | Vietnam National University","highestDevelopmentStatusID":"1","companyTruncated":"YAKULT HONSHA CO LTD \/ Bach Mai Hospital | Vietnam National University"}]

Find Clinical Drug Pipeline Developments & Deals by YAKULT HONSHA CO LTD

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          iPHEX India
                          Not Confirmed
                          iPHEX India
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          December 03, 2024

                          Lead Product(s) : 4'-Galactooligosaccharide

                          Therapeutic Area : Endocrinology

                          Highest Development Status : Undisclosed

                          Recipient : University of Aberdeen

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          iPHEX India
                          Not Confirmed
                          iPHEX India
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          May 29, 2024

                          Lead Product(s) : Fermented Milk

                          Therapeutic Area : Gastroenterology

                          Highest Development Status : Undisclosed

                          Recipient : University of Guadalajara

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          iPHEX India
                          Not Confirmed
                          iPHEX India
                          Not Confirmed

                          Lead Product(s) : Lactobacillus Casei Strain Shirota Fermented Milk

                          Therapeutic Area : Gastroenterology

                          Study Phase : Undisclosed

                          Sponsor : Bach Mai Hospital | Vietnam National University

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          August 09, 2023

                          Lead Product(s) : Lactobacillus Casei Strain Shirota Fermented Milk

                          Therapeutic Area : Gastroenterology

                          Highest Development Status : Undisclosed

                          Sponsor : Bach Mai Hospital | Vietnam National University

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          iPHEX India
                          Not Confirmed
                          iPHEX India
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          April 04, 2022

                          Lead Product(s) : Yakult

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Recipient : Endang Sutriswati Rahayu

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          iPHEX India
                          Not Confirmed
                          iPHEX India
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          August 02, 2021

                          Lead Product(s) : Yakult

                          Therapeutic Area : Musculoskeletal

                          Highest Development Status : Undisclosed

                          Recipient : Taipei Medical University

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          06

                          iPHEX India
                          Not Confirmed
                          iPHEX India
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          January 31, 2017

                          Lead Product(s) : Yakult

                          Therapeutic Area : Endocrinology

                          Highest Development Status : Undisclosed

                          Recipient : Loughborough University

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          07

                          iPHEX India
                          Not Confirmed
                          iPHEX India
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          December 01, 2015

                          Lead Product(s) : Probiotic

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : Japan Aerospace Exploration Agency

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          08

                          iPHEX India
                          Not Confirmed
                          iPHEX India
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          March 27, 2015

                          Lead Product(s) : Resminostat

                          Therapeutic Area : Oncology

                          Highest Development Status : Phase I/ Phase II

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          09

                          iPHEX India
                          Not Confirmed
                          iPHEX India
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          December 23, 2014

                          Lead Product(s) : TAS-118

                          Therapeutic Area : Oncology

                          Highest Development Status : Phase III

                          Recipient : Taiho Pharmaceutical

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          10

                          iPHEX India
                          Not Confirmed
                          iPHEX India
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          May 23, 2014

                          Lead Product(s) : Fermented Milk

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase II

                          Recipient : University of São Paulo General Hospital

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank